NEOS Investment Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $321K | Buy |
42,692
+3,528
| +9% | +$26.6K | ﹤0.01% | 579 |
|
|
2025
Q1 | $296K | Buy |
39,164
+10,731
| +38% | +$81.2K | 0.01% | 556 |
|
|
2024
Q4 | $346K | Buy |
28,433
+2,793
| +11% | +$34K | 0.01% | 546 |
|
|
2024
Q3 | $429K | Buy |
25,640
+1,617
| +7% | +$27.1K | 0.01% | 510 |
|
|
2024
Q2 | $419K | Buy |
24,023
+7,635
| +47% | +$133K | 0.02% | 482 |
|
|
2024
Q1 | $279K | Buy |
16,388
+482
| +3% | +$8.21K | 0.02% | 502 |
|
|
2023
Q4 | $162K | Buy |
+15,906
| New | +$162K | 0.02% | 506 |
|